Community pharmacist–led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer
Restricted accessBrief reportFirst published online November, 2017
Community pharmacist–led telephone follow-up enabled close management of everolimus-induced adverse events in an outpatient with metastatic breast cancer
RugoHSPritchardKIGnantMet al. Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. Ann Oncol2014;25:808-15.
2.
HortobagyiGN.Everolimus plus exemestane for the treatment of advanced breast cancer: a review of subanalyses from BOLERO-2. Neoplasia2015;17:279-88.
3.
BaselgaJCamponeMPiccartMet al. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer. N Engl J Med2012;366:520-9.
4.
ClariMFrigerioSRicceriFet al. Follow-up telephone calls to patients discharged after undergoing orthopaedic surgery: double-blind, randomised controlled trial of efficacy. J Clin Nurs2015;24:2736-44.
5.
ShidaTKatoTTomitaYet al. Preventive effect of gargling with sodium azulene sulfonate on everolimus-induced stomatitis. Palliat Care Res2014;9:122-7.
6.
PetersonDEO’ShaughnessyJARugoHSet al. Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice. Cancer Med2016;5: 1897-907.
7.
NesariMZakerimoghadamMRajabAet al. Effect of telephone follow-up on adherence to a diabetes therapeutic regimen. Jpn J Nurs Sci2010;7:121-8.
8.
LeahyMKrishnasamyMHerschtalAet al. Satisfaction with nurse-led telephone follow up for low to intermediate risk prostate cancer patients treated with radical radiotherapy: a comparative study. Eur J Oncol Nurs. 2013;17:162-9.
9.
NajafiSSShaabaniMMomennassabMet al. The nurse-led telephone follow-up on medication and dietary adherence among patients after myocardial infarction: a randomized controlled clinical trial. Int J Community Based Nurs Midwifery2016;4:199-208.
10.
LloydANafeesBNarewskaJet al. Health state utilities for metastatic breast cancer. Br J Cancer2006;96:683-90.
11.
NoguchiSMasudaNIwataHet al. Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2. Breast Cancer2014;21:703-14.
12.
KimuraMGoMIwaiMet al. Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agents. J Oncol Pharm Pract2017;23:413-21.
13.
BroadfieldLShaheenPRogezMet al. Guidelines for outpatient cancer care by community pharmacists. Can Pharm J (Ott)2017;150:24-31.
14.
van RooijTRixSMarshS. AntiC: a practice tool for the safe use of oral chemotherapeutics by community and hospital pharmacists. Can Pharm J (Ott)2015;148:118-24.
